drugset / Trial / NCT01768455

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects

NCT01768455

Phase 1 Completed 27 enrolled LG Life Sciences
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of the study was to investigate the pharmacokinetic drug interaction between gemigliptin and glimepiride in healthy male subjects after oral administration concomitantly and each alone.

Timeline

Start
2013-02
Primary completion
2013-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemigliptin Small molecule 50 mg Oral
Subject Glimepiride Small molecule 4 mg Oral

Indications

No indication recorded.